CoChat

Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice

Open access
Liu, Jiatong, Zhang, Jun, Lin, Xi, Boyce, Brendan F., Zhang, Hengwei, Xing, Lianping · 2022 · Journal of Clinical Investigation

The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index.

Abstract

Cellular senescence plays an important role in human diseases, including osteoporosis and osteoarthritis. Senescent cells (SCs) produce the senescence-associated secretory phenotype to affect the function of neighboring cells and SCs themselves. Delayed fracture healing is common in the elderly and is accompanied by reduced mesenchymal progenitor cells (MPCs). However, the contribution of cellular senescence to fracture healing in the aged has not to our knowledge been studied. Here, we used C57BL/6J 4-month-old young and 20-month-old aged mice and demonstrated a rapid increase in SCs in the fracture callus of aged mice. The senolytic drugs dasatinib plus quercetin enhanced fracture healing in aged mice. Aged callus SCs inhibited the growth and proliferation of callus-derived MPCs (CaMPCs) and expressed high levels of TGF-β1. TGF-β-neutralizing Ab prevented the inhibitory effects of aged callus SCs on CaMPCs and promoted fracture healing in aged mice, which was associated with increased CaMPCs and proliferating cells. Thus, fracture triggered a significant cellular senescence in the callus cells of aged mice, which inhibited MPCs by expressing TGF-β1. Short-term administration of dasatinib plus quercetin depleted callus SCs and accelerated fracture healing in aged mice. Senolytic drugs represent a promising therapy, while TGF-β1 signaling is a molecular mechanism for fractures in the elderly via SCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci148073

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Increase in p16+ SCs in fracture callus of aged mice. Young and aged mice underwent tibial fracture surgery and were sacrificed at 10 dpf. (A) Expression of p16 and p21 in callus tissue was measured by qPCR at the indicated time points. n = 3. Relative mRNA expression is the fold change versus young samples at time 0 as 1. *P < 0.05 aged versus young; #P < 0.05 young versus young 0 dpf; and ^P < 0.05 aged versus aged 0 dpf, by 2-way ANOVA followed by Tukey’s post hoc test. (B and C) Frozen sections of callus were immunostained with anti-p16 Ab or SA–β-gal. External callus is indicated by a dashed line and cartilage by a solid line. WB, woven bone. (B) Representative images showing increased p16+ cells in the aged sample. Scale bar: 1 mm. The number and percentage of p16+ cells were quantified by ImageJ. n = 4. (C) Representative images showing increased SA–β-gal+ cells in the aged sample. Scale bar: 1 mm. Original magnification, ×7 (enlarged insets in B) and ×3.5 (enlarged insets in C). SA–β-gal+ cells were quantified by ImageJ. n = 3. *P < 0.05, by unpaired, 2-tailed Student’s t test.
Figure 1 Increase in p16+ SCs in fracture callus of aged mice. Young and aged mice underwent tibial fracture surgery and were sacrificed at 10 dpf. (A) Expression of p16 and p21 in callus tissue was measured by qPCR at the indicated time points. n = 3. Relative mRNA expression is the fold change versus young samples at time 0 as 1. *P < 0.05 aged versus young; #P < 0.05 young versus young 0 dpf; and ^P < 0.05 aged versus aged 0 dpf, by 2-way ANOVA followed by Tukey’s post hoc test. (B and C) Frozen sections of callus were immunostained with anti-p16 Ab or SA–β-gal. External callus is indicated by a dashed line and cartilage by a solid line. WB, woven bone. (B) Representative images showing increased p16+ cells in the aged sample. Scale bar: 1 mm. The number and percentage of p16+ cells were quantified by ImageJ. n = 4. (C) Representative images showing increased SA–β-gal+ cells in the aged sample. Scale bar: 1 mm. Original magnification, ×7 (enlarged insets in B) and ×3.5 (enlarged insets in C). SA–β-gal+ cells were quantified by ImageJ. n = 3. *P < 0.05, by unpaired, 2-tailed Student’s t test.CC BY · PubMed Central
Figure 2 Increase in γ-H2AX+ SCs in fracture callus of aged mice. Young and aged mice were sacrificed at 10 dpf. (A) Cells from callus tissues were subjected to flow cytometry to detect SPiDER–β-gal and γ-H2AX. Quantification of the number and percentage of SPiDER–β-gal+, γ-H2AX+, and SPiDER–β-gal+γ-H2AX+ cells. n = 3. The numbers in the plots indicate the percentage of positive cells from a representative sample. *P < 0.05, by unpaired, 2-tailed Student’s t test. (B) Frozen sections of callus immunostained with p16 or γ-H2AX Ab. H&E-stained images (upper panels) indicate the location of the enlarged area in the immunostained sections (middle and lower panels). Scale bar: 250 μm. Original magnification, ×3 (enlarged insets). p16 and γ-H2AX double-positive cells are indicated by arrows. The number and percentage of p16+γ-H2AX+ cells were quantified by ImageJ. n = 4. *P < 0.05, by unpaired, 2-tailed Student’s t test.
Figure 2 Increase in γ-H2AX+ SCs in fracture callus of aged mice. Young and aged mice were sacrificed at 10 dpf. (A) Cells from callus tissues were subjected to flow cytometry to detect SPiDER–β-gal and γ-H2AX. Quantification of the number and percentage of SPiDER–β-gal+, γ-H2AX+, and SPiDER–β-gal+γ-H2AX+ cells. n = 3. The numbers in the plots indicate the percentage of positive cells from a representative sample. *P < 0.05, by unpaired, 2-tailed Student’s t test. (B) Frozen sections of callus immunostained with p16 or γ-H2AX Ab. H&E-stained images (upper panels) indicate the location of the enlarged area in the immunostained sections (middle and lower panels). Scale bar: 250 μm. Original magnification, ×3 (enlarged insets). p16 and γ-H2AX double-positive cells are indicated by arrows. The number and percentage of p16+γ-H2AX+ cells were quantified by ImageJ. n = 4. *P < 0.05, by unpaired, 2-tailed Student’s t test.CC BY · PubMed Central
Figure 3 Senolytic drugs enhance fracture healing in aged mice by removing SCs. Young and aged mice underwent tibial fracture surgery. (A) Experimental outline. Young and aged mice were given 5 mg/kg dasatinib (D) + 50 mg/kg quercetin (Q) or vehicle (V) by gavage on 1, 3, 5, and 7 dpf and sacrificed at 10 or 28 dpf. (B) Expression of p16 and p21 in callus tissues was measured by qPCR at 10 dpf. n = 3. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. *P < 0.05 vehicle versus D+Q, by 2-way ANOVA followed by Tukey’s post hoc test. (C) Callus volume was measured by micro-CT. n = 3–4. (D) Representative ABH-stained sections showing higher woven bone and callus areas in D+Q-treated mice. Scale bar: 1 mm. (E) Woven bone and cartilage areas were analyzed by ImageJ. n = 3–4. (F) Bone stiffness, strength, and toughness were assessed by biomechanical testing at 28 dpf. n = 6. *P < 0.05 vehicle versus D+Q treatment; #P < 0.05, for D+Q-treated aged mice versus vehicle-treated young mice; 2-way ANOVA followed by Tukey’s post hoc test (C, E, and F). μCT, micro-CT.
Figure 3 Senolytic drugs enhance fracture healing in aged mice by removing SCs. Young and aged mice underwent tibial fracture surgery. (A) Experimental outline. Young and aged mice were given 5 mg/kg dasatinib (D) + 50 mg/kg quercetin (Q) or vehicle (V) by gavage on 1, 3, 5, and 7 dpf and sacrificed at 10 or 28 dpf. (B) Expression of p16 and p21 in callus tissues was measured by qPCR at 10 dpf. n = 3. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. *P < 0.05 vehicle versus D+Q, by 2-way ANOVA followed by Tukey’s post hoc test. (C) Callus volume was measured by micro-CT. n = 3–4. (D) Representative ABH-stained sections showing higher woven bone and callus areas in D+Q-treated mice. Scale bar: 1 mm. (E) Woven bone and cartilage areas were analyzed by ImageJ. n = 3–4. (F) Bone stiffness, strength, and toughness were assessed by biomechanical testing at 28 dpf. n = 6. *P < 0.05 vehicle versus D+Q treatment; #P < 0.05, for D+Q-treated aged mice versus vehicle-treated young mice; 2-way ANOVA followed by Tukey’s post hoc test (C, E, and F). μCT, micro-CT.CC BY · PubMed Central
Figure 4 Callus-derived cells have properties of MPCs. Callus cells were isolated from young mice at 10 dpf. Third-passage cells were used. (A) Immunophenotypic analysis by flow cytometry showing cells expressing MPC surface markers. Data are representative of cells from 3 mice. (B) qPCR was performed to measure the expression of genes associated with OB, chondrocyte, or adipocyte differentiation 48 hours after cells were cultured in the various inducing media. n = 3 wells from a pool of 3 mice. Relative mRNA expression is the fold change versus PBS-treated cells as 1. *P < 0.05, by unpaired, 2-tailed Student’s t test. Original magnification, ×100. (C) In vivo bone formation assay. Micro-CT images show newly formed bone in cortical bone defects 6 weeks after cell injection. Adi, adipocytes; Cor, cortical bone–derived cells. n = 3. *P < 0.05, for callus versus the other groups, by 1-way ANOVA followed by Tukey’s post hoc test. Only comparisons between callus versus other bones are shown.
Figure 4 Callus-derived cells have properties of MPCs. Callus cells were isolated from young mice at 10 dpf. Third-passage cells were used. (A) Immunophenotypic analysis by flow cytometry showing cells expressing MPC surface markers. Data are representative of cells from 3 mice. (B) qPCR was performed to measure the expression of genes associated with OB, chondrocyte, or adipocyte differentiation 48 hours after cells were cultured in the various inducing media. n = 3 wells from a pool of 3 mice. Relative mRNA expression is the fold change versus PBS-treated cells as 1. *P < 0.05, by unpaired, 2-tailed Student’s t test. Original magnification, ×100. (C) In vivo bone formation assay. Micro-CT images show newly formed bone in cortical bone defects 6 weeks after cell injection. Adi, adipocytes; Cor, cortical bone–derived cells. n = 3. *P < 0.05, for callus versus the other groups, by 1-way ANOVA followed by Tukey’s post hoc test. Only comparisons between callus versus other bones are shown.CC BY · PubMed Central
Figure 5 Callus cells treated with H2O 2 inhibit the growth of CaMPCs, which is blocked by senolytic drugs. Callus tissues from young mice sacrificed at 10 dpf were used. (A) Callus pieces were treated with 50 μM H2O2 for 8 hours, changed to fresh culture media, and then cultured for an additional 2 days. Cells that grew out from and within callus pieces were harvested. Expression of p16, p19, p18, and p21 was measured by qPCR. n = 4 wells. The experiment was repeated once. Relative mRNA expression is the fold change versus vehicle-treated cells as 1. (B) SA–β-gal staining was performed, and the percentage of SA–β-gal+ cells was measured by ImageJ. n = 3 wells. The experiment was repeated once. (C) The percentages of p16+ cells (left panel) and CD45– and CD45+CD11b+ cells in p16+ cells (right panel) were determined by flow cytometry. n = 4 wells. The experiment was repeated once. (D) Callus pieces were treated with H2O2 as in A to generate SCs, and CM was collected. CaMPCs were treated with CM for 2 days. Cell growth assessed by methylene blue staining, and positively stained areas were measured by ImageJ. n = 4 wells. The experiment was repeated twice. *P < 0.05, by unpaired, 2-tailed Student’s t test (A–D). (E) Callus pieces were treated with H2O2 for 4 hours and then incubated with 200 nM dasatinib plus 20 μM quercetin or vehicle for 24 hours. CM was collected and used to treat CaMPCs for 2 days. Cell growth was assessed as described in E. n = 4 wells. *P < 0.05 vehicle versus other the groups; #P < 0.05 H2O2 versus H2O2 plus D+Q, by 1-way anova followed by Tukey’s post hoc test. Veh, vehicle.
Figure 5 Callus cells treated with H2O 2 inhibit the growth of CaMPCs, which is blocked by senolytic drugs. Callus tissues from young mice sacrificed at 10 dpf were used. (A) Callus pieces were treated with 50 μM H2O2 for 8 hours, changed to fresh culture media, and then cultured for an additional 2 days. Cells that grew out from and within callus pieces were harvested. Expression of p16, p19, p18, and p21 was measured by qPCR. n = 4 wells. The experiment was repeated once. Relative mRNA expression is the fold change versus vehicle-treated cells as 1. (B) SA–β-gal staining was performed, and the percentage of SA–β-gal+ cells was measured by ImageJ. n = 3 wells. The experiment was repeated once. (C) The percentages of p16+ cells (left panel) and CD45– and CD45+CD11b+ cells in p16+ cells (right panel) were determined by flow cytometry. n = 4 wells. The experiment was repeated once. (D) Callus pieces were treated with H2O2 as in A to generate SCs, and CM was collected. CaMPCs were treated with CM for 2 days. Cell growth assessed by methylene blue staining, and positively stained areas were measured by ImageJ. n = 4 wells. The experiment was repeated twice. *P < 0.05, by unpaired, 2-tailed Student’s t test (A–D). (E) Callus pieces were treated with H2O2 for 4 hours and then incubated with 200 nM dasatinib plus 20 μM quercetin or vehicle for 24 hours. CM was collected and used to treat CaMPCs for 2 days. Cell growth was assessed as described in E. n = 4 wells. *P < 0.05 vehicle versus other the groups; #P < 0.05 H2O2 versus H2O2 plus D+Q, by 1-way anova followed by Tukey’s post hoc test. Veh, vehicle.CC BY · PubMed Central
Figure 6 CM from aged callus inhibits the growth of MPCs, which is prevented by senolytic drugs. Young and aged mice were sacrificed on 10 dpf. (A) Callus pieces were cultured for 2 days to generate CM. CaMPCs were treated with 30% of CM for 2 days and subjected to growth, proliferation, apoptosis, and senescence analyses. (B) Cell growth, as in Figure 5E. n = 4 wells. The experiment was repeated twice. (C) Cell proliferation was assessed according to the percentage of cells incorporating BrdU. BrdU+ cells are indicated by white arrowheads. Scale bars: 100 mm. Original magnification, ×4 (enlarged insets). n = 4 wells. The experiment was repeated once. (D) Cell apoptosis was measured by flow cytometry as the percentage of annexin V+ cells. The experiment was repeated once. (E) Cellular was senescence assessed according to the percentage of SA–β-gal+ cells. n = 4 wells. The experiment was repeated once. (F) The expression of senescence markers was determined by qPCR. n = 3 wells. Relative mRNA expression is the fold change versus young cells as 1. The experiment was repeated once. *P < 0.05, by unpaired, 2-tailed Student’s t test (B, C, E, and F). (G) CaMPCs were treated with CM with or without 200 nM dasatinib plus 20 μM quercetin. n = 4 wells. The experiment was repeated once. *P < 0.05, for vehicle versus D+Q, by 2-way ANOVA followed by Tukey’s post hoc test. Only comparisons between vehicle versus D+Q treatment in young or aged mice are shown. ctl, control.
Figure 6 CM from aged callus inhibits the growth of MPCs, which is prevented by senolytic drugs. Young and aged mice were sacrificed on 10 dpf. (A) Callus pieces were cultured for 2 days to generate CM. CaMPCs were treated with 30% of CM for 2 days and subjected to growth, proliferation, apoptosis, and senescence analyses. (B) Cell growth, as in Figure 5E. n = 4 wells. The experiment was repeated twice. (C) Cell proliferation was assessed according to the percentage of cells incorporating BrdU. BrdU+ cells are indicated by white arrowheads. Scale bars: 100 mm. Original magnification, ×4 (enlarged insets). n = 4 wells. The experiment was repeated once. (D) Cell apoptosis was measured by flow cytometry as the percentage of annexin V+ cells. The experiment was repeated once. (E) Cellular was senescence assessed according to the percentage of SA–β-gal+ cells. n = 4 wells. The experiment was repeated once. (F) The expression of senescence markers was determined by qPCR. n = 3 wells. Relative mRNA expression is the fold change versus young cells as 1. The experiment was repeated once. *P < 0.05, by unpaired, 2-tailed Student’s t test (B, C, E, and F). (G) CaMPCs were treated with CM with or without 200 nM dasatinib plus 20 μM quercetin. n = 4 wells. The experiment was repeated once. *P < 0.05, for vehicle versus D+Q, by 2-way ANOVA followed by Tukey’s post hoc test. Only comparisons between vehicle versus D+Q treatment in young or aged mice are shown. ctl, control.CC BY · PubMed Central
Figure 7 SCs in aged callus express high levels of TGF-β1, and TGF-β neutralization prevents the inhibitory effects of aged SCs on MPCs. Young and aged mice were sacrificed on 10 dpf. (A) Heatmap of the expression of SASP factors in callus as determined by qPCR. n = 3. (B) Expression of SASP factors in callus and nonfractured bone was assessed by qPCR. n = 4. Two-way ANOVA followed by Tukey’s post hoc test. (C) p16+ SCs isolated from young and aged callus. Expression of SASP factors examined by qPCR. *P < 0.05, by unpaired, 2-tailed Student’s t test. (D) p16+, TGF-β1+, and p16+TGF-β1+ cells were identified by flow cytometry. (E) Fold changes in p16+, TGF-β1+, and p16+TGF-β1+ cell percentages in callus and nonfractured tibiae of aged versus young mice. n = 4–6. *P < 0.05, for callus versus bone, by unpaired, 2-tailed Student’s t test. (F) Percentage of p16+TGF-β1+ cells in callus and nonfractured tibiae. *P < 0.05; ^P < 0.05; #P < 0.05, for aged versus young, by 2-way ANOVA followed by Tukey’s post hoc test. (G) Expression of TGF-β1 in callus tissues following D+Q treatment by as determined by Western blotting. (H) CaMPCs were treated for 2 days with CM from young or aged callus with or without TGF-β–neutralizing Ab or IgG. Cell growth and proliferation were assessed by methylene blue staining or a BrdU incorporation assay. n = 4 wells. *P < 0.05, for IgG versus anti–TGF-β Ab; #P < 0.05, for aged anti–TGF-β Ab versus young IgG, by 2-way ANOVA followed by Tukey’s post hoc test. (I) Concentration of active TGF-β1 in CM from young and aged callus cultures measured by ELISA. *P < 0.05, by unpaired, 2-tailed Student’s t test. (J) Callus pieces were harvested from young and aged mice and infected with Tgfb1 or scrambled (Ctl) shRNA lentivirus. CM was collected. The expression of Tgfb1 was measured by qPCR. CaMPCs were treated with the CM. Cell growth was assessed using a CCK8 kit. n = 3 wells. *P < 0.05, for control versus Tgfb1 shRNA, by 2-way ANOVA followed by Tukey’s post hoc test. The experiment was repeated once.
Figure 7 SCs in aged callus express high levels of TGF-β1, and TGF-β neutralization prevents the inhibitory effects of aged SCs on MPCs. Young and aged mice were sacrificed on 10 dpf. (A) Heatmap of the expression of SASP factors in callus as determined by qPCR. n = 3. (B) Expression of SASP factors in callus and nonfractured bone was assessed by qPCR. n = 4. Two-way ANOVA followed by Tukey’s post hoc test. (C) p16+ SCs isolated from young and aged callus. Expression of SASP factors examined by qPCR. *P < 0.05, by unpaired, 2-tailed Student’s t test. (D) p16+, TGF-β1+, and p16+TGF-β1+ cells were identified by flow cytometry. (E) Fold changes in p16+, TGF-β1+, and p16+TGF-β1+ cell percentages in callus and nonfractured tibiae of aged versus young mice. n = 4–6. *P < 0.05, for callus versus bone, by unpaired, 2-tailed Student’s t test. (F) Percentage of p16+TGF-β1+ cells in callus and nonfractured tibiae. *P < 0.05; ^P < 0.05; #P < 0.05, for aged versus young, by 2-way ANOVA followed by Tukey’s post hoc test. (G) Expression of TGF-β1 in callus tissues following D+Q treatment by as determined by Western blotting. (H) CaMPCs were treated for 2 days with CM from young or aged callus with or without TGF-β–neutralizing Ab or IgG. Cell growth and proliferation were assessed by methylene blue staining or a BrdU incorporation assay. n = 4 wells. *P < 0.05, for IgG versus anti–TGF-β Ab; #P < 0.05, for aged anti–TGF-β Ab versus young IgG, by 2-way ANOVA followed by Tukey’s post hoc test. (I) Concentration of active TGF-β1 in CM from young and aged callus cultures measured by ELISA. *P < 0.05, by unpaired, 2-tailed Student’s t test. (J) Callus pieces were harvested from young and aged mice and infected with Tgfb1 or scrambled (Ctl) shRNA lentivirus. CM was collected. The expression of Tgfb1 was measured by qPCR. CaMPCs were treated with the CM. Cell growth was assessed using a CCK8 kit. n = 3 wells. *P < 0.05, for control versus Tgfb1 shRNA, by 2-way ANOVA followed by Tukey’s post hoc test. The experiment was repeated once.CC BY · PubMed Central
Figure 8 TGF-β neutralization enhances fracture healing in aged mice. Young and aged mice underwent tibial fracture surgery. (A) The expression of Tgfb1 in fracture callus at indicated time points was measured by qPCR. n = 3. Relative mRNA expression is the fold-change versus young mice as 1. (B) The concentration of active TGF-β1 protein in fracture callus at indicated time points was measured by ELISA. n = 4. *P < 0.05, for aged versus young; #P < 0.05, for young versus young 0 dpf; ^P < 0.05, for aged versus aged 0 dpf, by 2-way ANOVA followed by Tukey’s post hoc test (A and B). (C) Outline of the experimental design. Aged mice were given 2 μg in 10 μL TGF-β Ab, 1D11, or isotype IgG vehicle by intra-callus injection on 1, 3, 5, and 7 dpf and sacrificed on 10 dpf (D–F and H–J) or 28 dpf (G). n = 4–5. (D) Callus volume was measured by micro-CT. *P < 0.05, by unpaired, 2-tailed Student’s t test. (E) Representative images of ABH-stained sections showing more woven bone and callus areas in the anti–TGF-β Ab–treated mice. Scale bar: 1 mm. (F) Woven bone and cartilage areas were analyzed using Visiopharm software. (G) Bone stiffness, strength and toughness were assessed by biomechanical testing at 28 dpf. (H) The percentage and number of MPCs identified as CD45–CD31–CD105+ cells in fracture callus were determined by flow cytometry. (I) Representative paraffin sections of callus immunostained with anti-Ki67 Ab to detect proliferating cells (arrowheads). External callus is indicated by the dashed lines. Scale bars: 500 μm. Original magnification, ×4 (enlarged insets). (J) The percentage of Ki67+ cells was quantified by ImageJ. *P < 0.05, by unpaired, 2-tailed Student’s t test (F, G, H, and J).
Figure 8 TGF-β neutralization enhances fracture healing in aged mice. Young and aged mice underwent tibial fracture surgery. (A) The expression of Tgfb1 in fracture callus at indicated time points was measured by qPCR. n = 3. Relative mRNA expression is the fold-change versus young mice as 1. (B) The concentration of active TGF-β1 protein in fracture callus at indicated time points was measured by ELISA. n = 4. *P < 0.05, for aged versus young; #P < 0.05, for young versus young 0 dpf; ^P < 0.05, for aged versus aged 0 dpf, by 2-way ANOVA followed by Tukey’s post hoc test (A and B). (C) Outline of the experimental design. Aged mice were given 2 μg in 10 μL TGF-β Ab, 1D11, or isotype IgG vehicle by intra-callus injection on 1, 3, 5, and 7 dpf and sacrificed on 10 dpf (D–F and H–J) or 28 dpf (G). n = 4–5. (D) Callus volume was measured by micro-CT. *P < 0.05, by unpaired, 2-tailed Student’s t test. (E) Representative images of ABH-stained sections showing more woven bone and callus areas in the anti–TGF-β Ab–treated mice. Scale bar: 1 mm. (F) Woven bone and cartilage areas were analyzed using Visiopharm software. (G) Bone stiffness, strength and toughness were assessed by biomechanical testing at 28 dpf. (H) The percentage and number of MPCs identified as CD45–CD31–CD105+ cells in fracture callus were determined by flow cytometry. (I) Representative paraffin sections of callus immunostained with anti-Ki67 Ab to detect proliferating cells (arrowheads). External callus is indicated by the dashed lines. Scale bars: 500 μm. Original magnification, ×4 (enlarged insets). (J) The percentage of Ki67+ cells was quantified by ImageJ. *P < 0.05, by unpaired, 2-tailed Student’s t test (F, G, H, and J).CC BY · PubMed Central
Figure 9 Senolytic drugs enhance fracture healing in female aged mice and reduce the expression of SASP factors in callus tissues. Young and aged female mice underwent tibial fracture surgery. (A) Experimental outline. Mice were given 5 mg/kg dasatinib plus 50 mg/kg quercetin or vehicle by gavage on 3, 7, and 11 dpf and sacrificed on 14 dpf. n = 4–5. (B) The expression of p16 and p21 in callus tissues was determined by qPCR. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. (C) Callus volume was measured by micro-CT. (D) Representative images of ABH-stained sections showing more woven bone and callus areas in D+Q-treated aged mice than in vehicle-treated aged mice. Scale bar: 1 mm. (E) Woven bone and cartilage areas were analyzed using Visiopharm software. (F) The expression of SASP factors in callus tissues was measured by qPCR. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. (G) The concentration of active TGF-β1 protein in serum was measured by ELISA. *P < 0.05, for vehicle versus D+Q or vehicle young versus vehicle aged, by 2-way ANOVA followed by Tukey’s post hoc test (B, C, and E–G). (H) The expression of OB and OC marker genes in nonfractured bone and callus was determined by qPCR. Relative mRNA expression is the fold change versus bone samples from vehicle-treated young mice as 1. *P < 0.05 vehicle versus D+Q; #P < 0.05, for vehicle young bone versus vehicle aged bone, by 2-way ANOVA followed by Tukey’s post hoc test.
Figure 9 Senolytic drugs enhance fracture healing in female aged mice and reduce the expression of SASP factors in callus tissues. Young and aged female mice underwent tibial fracture surgery. (A) Experimental outline. Mice were given 5 mg/kg dasatinib plus 50 mg/kg quercetin or vehicle by gavage on 3, 7, and 11 dpf and sacrificed on 14 dpf. n = 4–5. (B) The expression of p16 and p21 in callus tissues was determined by qPCR. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. (C) Callus volume was measured by micro-CT. (D) Representative images of ABH-stained sections showing more woven bone and callus areas in D+Q-treated aged mice than in vehicle-treated aged mice. Scale bar: 1 mm. (E) Woven bone and cartilage areas were analyzed using Visiopharm software. (F) The expression of SASP factors in callus tissues was measured by qPCR. Relative mRNA expression is the fold change versus vehicle-treated young mice as 1. (G) The concentration of active TGF-β1 protein in serum was measured by ELISA. *P < 0.05, for vehicle versus D+Q or vehicle young versus vehicle aged, by 2-way ANOVA followed by Tukey’s post hoc test (B, C, and E–G). (H) The expression of OB and OC marker genes in nonfractured bone and callus was determined by qPCR. Relative mRNA expression is the fold change versus bone samples from vehicle-treated young mice as 1. *P < 0.05 vehicle versus D+Q; #P < 0.05, for vehicle young bone versus vehicle aged bone, by 2-way ANOVA followed by Tukey’s post hoc test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 76 references

Cited by

See all 113

Metadata

Authors
Liu, J., Zhang, J., Lin, X., Boyce, B. F., Zhang, H., & Xing, L.
Affiliations
  • University of Rochester Medicine (US)
  • Suzhou Institute of Systems Medicine (CN)
Corresponding author
  • Zhang, Hengwei
  • Xing, Lianping
Venue
Journal of Clinical Investigation
Published
2022-04-15
Volume
132
Issue
8
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4224055822
Cited by
112
References
79
Citations by year
2026: 34 · 2025: 31 · 2024: 28 · 2023: 14 · 2022: 5
FWCI
12.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NIH Office of the Director (AG059775, AG049994, AR069789, P30AR061307,AR069655)
  • National Natural Science Foundation of China (No.81473451,No.31771560)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
cellular senescence, senescence-associated secretory phenotype, fracture healing, aging, TGF-β1, mesenchymal progenitor cells, fracture callus, senolytics, dasatinib, quercetin, osteoporosis, osteoarthritis
MeSH terms
Dasatinib, Animals, Mice, Inbred C57BL, Quercetin, Cellular Senescence, Fracture Healing, Fractures, Bone, Mice, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. https://app.cochat.ai/papers/10.1172/jci148073
The paper
Liu, J., Zhang, J., Lin, X., Boyce, B. F., Zhang, H., & Xing, L. (2022). Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci148073

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.